To further explore the feasibility of TIM-3 blockade for overcoming PD-1 resistance, PD-1 blockade combined with TIM-3 blockade was applied in murine HNSCC models. This evidence concerns the gene HAVCR2 and head and neck squamous cell carcinoma.